Premium senior advisory for biotech leaders
Accelero Advisory connects scientific judgment, strategy, capital and execution in one accountable mandate. We help leadership teams move from complex scientific potential to a clear, financed and executable path, staying involved from critical decisions through financing and implementation.
Why Accelero
01
Clarity
A credible path from scientific potential to value creation, connecting science, strategy, capital and execution.
02
Confidence
An investor-ready proposition that stands up to scrutiny and stays credible from boardroom decisions through financing.
03
Momentum
Decisions that translate into financing, partnerships and execution, building the capabilities required for the next stage.
Our strategic pillars
Leadership
Two capabilities. One value agenda. Integrated judgment around the decisions that matter.
Detlef Krawinkel
Lead · Value & Capital
From Critical Value Decision → investment case → investor access → capital raise. What creates value, and how do we finance it? Value Strategy • Enterprise Value • Capital Raise • Investor Connectivity • Strategic Relationships.
Dr. Barbara Troup
Lead · Strategy & Transformation
From strategic choice → leadership alignment → transformation → execution. What must the organization do to deliver it? Enterprise Strategy • Leadership • Organization • Governance • Transformation • Execution.
Senior expertise from decision through delivery
Edward Gudaitis
Market Access und Commercial Strategy
Brings market access and commercial strategy together to turn scientific potential into sustainable revenue growth.
Ruben Giorginio
Pre-clinical and Clinical Development
Brings together scientific, clinical and regulatory perspectives to design development paths that de-risk pivotal decisions.
Dr. Peter Stangier
Finance and Capital Raising
Advises biotech leaders on structuring and securing the right mix of capital to fund critical development milestones.
Beat Widler
Quality, Safety & Pharmacovigilance
Ensures that benefit–risk, safety and quality considerations are embedded in every critical development and commercialization decision.
Dr. Peter Schiemann
Regulatory Strategy & Manufacturing
Aligns regulatory strategy and manufacturing readiness so that late-stage and launch plans are both compliant and commercially viable.
Bertrand Bonnot
Launch Readiness and Market Development
Shapes launch and market development strategies that turn scientific differentiation into early adoption and durable market presence.
Start a conversation with Accelero
We work with biotech leaders when clarity, credibility and momentum matter most. Bring us in when the next decision must remain credible through financing, partnering and implementation.